# Telomir Pharmaceuticals, Inc.: Form 8-K, filed May 21, 2025

- Company: [Telomir Pharmaceuticals, Inc.](/companies/telo.md) (CIK 1971532)
- Form: 8-K
- Filed: 2025-05-21
- Accepted by EDGAR: May 21, 2025, 08:45 ET
- Period: 2025-05-19
- Accession: 0001641172-25-011868
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1971532/000164117225011868/form8-k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1971532/000164117225011868/

## Items reported

- Item 3.02: Unregistered sale of equity
- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1971532/000164117225011868/form8-k.htm

Filed May 21, 2025.
Source: SEC EDGAR, the filing index for accession 0001641172-25-011868. Last ingested by Listed: Nov 6, 2026, 17:47 ET. No prices; not investment advice.